Michigan Accelerator Fund I (MAF-1) has made a $750,000 Series A-1 investment in Swift Biosciences, Inc., the seventh company it has funded.
Start Garden announced they have invested $500,000 in Grand Rapids-based Blue Medora. Grand Angels, a regional group of angel investors, also announced that 20 of their members will also be making investments in Blue Medora which cumulatively equal an additional $750,000, bringing the total amount raised to fund the startup to $1.25 million.
The Small Business Administration has issued a call for applications from fund managers for the second year of its early-stage venture capital program.
VC Journal is writing a story for early 2013 about the arrival of the autonomous car, and its future impact on the U.S. automotive industry.
Can venture capital fund-of-funds boost innovation and regional growth?
“The MEDC is looking to receive information from companies that have expertise in early stage technology company valuation practices, along with valuation methods utilized, and pricing models for providing those services.”
Skills Matter, Europe’s largest provider of open source and agile training and events, today announced a $5 million investment from Beringea, the growth capital investor that manages the Proven Venture Capital Trusts.
ProNAi Therapeutics, Inc., a private DNAi cancer drug development company, recently concluded its initial human clinical trial of PNT2258. The company also expanded its management team with the recent appointments of board member and venture capital investor Mina Sooch, MBA, as President and CEO, and Dr. Richard Messmann, MD, as Chief Medical Officer.
Two MVCA members, Augment Ventures and MK Capital recently made investments in LLamasoft, Inc., the global leader in supply chain design software. LLamasoft enables companies to model, optimize and simulate their supply chain network, leading to major improvements in cost, service, sustainability, and risk mitigation, with unparalleled supply chain design and predictive analytics solutions. “LLamasoft […]
Renaissance Venture Capital Fund recently made its first investment commitment from its Renaissance II fund. The commitment was made to Allos II, a Cincinnati and Indianapolis-based venture capital fund targeting investments in early-stage technology companies based in the Midwest. The fund’s investor group, which includes institutional investors such as Indiana University Foundation, Purdue University and […]